PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Ringelstein, E. Bernd
TI  - AXIS 2 Clinical Outcomes No Different than Placebo
DP  - 2012 May 01
TA  - MD Conference Express
PG  - 12--13
VI  - 12
IP  - 1
4099  - http://mdc.sagepub.com/content/12/1/12.short
4100  - http://mdc.sagepub.com/content/12/1/12.full
AB  - AX200 was a novel and promising drug candidate with a comprehensive preclinical and clinical package that fulfilled Stroke Therapy Academic Industry Roundtable (STAIR) and European Stroke Organization recommendations; yet, no difference was observed in clinical outcome or imaging compared with placebo in acute ischemic stroke patients, according to results from the AX200 for the Treatment of Ischemic Stroke Phase 3 trial [AXIS-2; NCT00927836].